Maintaining effective treatment in dementia: A case series on patients switched to rivastigmine

Carl Sadowsky, Keith Edwards, Bijan Etemad, Martin Farlow

Research output: Contribution to journalArticle

Abstract

In the clinical management of Alzheimer's disease (AD), switching cholinesterase (ChE) inhibitors is becoming an increasingly common practice following non-response or safety/tolerability problems with an initial agent. Data from clinical studies has demonstrated that approximately half of all patients benefit from switching. In this paper, we present eight case studies from our own clinical experience of switching ChE inhibitors, and highlight some of the potential benefits associated with this practice.

Original languageEnglish
Pages (from-to)71-75
Number of pages5
JournalPrimary Care Psychiatry
Volume9
Issue number3
DOIs
StatePublished - 2004

Fingerprint

Rivastigmine
Cholinesterase Inhibitors
Dementia
Alzheimer Disease
Safety
Therapeutics

Keywords

  • Alzheimer's disease
  • Cholinesterase inhibitors
  • Rivastigmine
  • Switching

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Maintaining effective treatment in dementia : A case series on patients switched to rivastigmine. / Sadowsky, Carl; Edwards, Keith; Etemad, Bijan; Farlow, Martin.

In: Primary Care Psychiatry, Vol. 9, No. 3, 2004, p. 71-75.

Research output: Contribution to journalArticle

Sadowsky, Carl ; Edwards, Keith ; Etemad, Bijan ; Farlow, Martin. / Maintaining effective treatment in dementia : A case series on patients switched to rivastigmine. In: Primary Care Psychiatry. 2004 ; Vol. 9, No. 3. pp. 71-75.
@article{485faf5687c84961abda3c17fbdfb5da,
title = "Maintaining effective treatment in dementia: A case series on patients switched to rivastigmine",
abstract = "In the clinical management of Alzheimer's disease (AD), switching cholinesterase (ChE) inhibitors is becoming an increasingly common practice following non-response or safety/tolerability problems with an initial agent. Data from clinical studies has demonstrated that approximately half of all patients benefit from switching. In this paper, we present eight case studies from our own clinical experience of switching ChE inhibitors, and highlight some of the potential benefits associated with this practice.",
keywords = "Alzheimer's disease, Cholinesterase inhibitors, Rivastigmine, Switching",
author = "Carl Sadowsky and Keith Edwards and Bijan Etemad and Martin Farlow",
year = "2004",
doi = "10.1185/135525704X3447",
language = "English",
volume = "9",
pages = "71--75",
journal = "Primary Care Psychiatry",
issn = "1355-2570",
publisher = "Librapharm",
number = "3",

}

TY - JOUR

T1 - Maintaining effective treatment in dementia

T2 - A case series on patients switched to rivastigmine

AU - Sadowsky, Carl

AU - Edwards, Keith

AU - Etemad, Bijan

AU - Farlow, Martin

PY - 2004

Y1 - 2004

N2 - In the clinical management of Alzheimer's disease (AD), switching cholinesterase (ChE) inhibitors is becoming an increasingly common practice following non-response or safety/tolerability problems with an initial agent. Data from clinical studies has demonstrated that approximately half of all patients benefit from switching. In this paper, we present eight case studies from our own clinical experience of switching ChE inhibitors, and highlight some of the potential benefits associated with this practice.

AB - In the clinical management of Alzheimer's disease (AD), switching cholinesterase (ChE) inhibitors is becoming an increasingly common practice following non-response or safety/tolerability problems with an initial agent. Data from clinical studies has demonstrated that approximately half of all patients benefit from switching. In this paper, we present eight case studies from our own clinical experience of switching ChE inhibitors, and highlight some of the potential benefits associated with this practice.

KW - Alzheimer's disease

KW - Cholinesterase inhibitors

KW - Rivastigmine

KW - Switching

UR - http://www.scopus.com/inward/record.url?scp=11344257636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11344257636&partnerID=8YFLogxK

U2 - 10.1185/135525704X3447

DO - 10.1185/135525704X3447

M3 - Article

AN - SCOPUS:11344257636

VL - 9

SP - 71

EP - 75

JO - Primary Care Psychiatry

JF - Primary Care Psychiatry

SN - 1355-2570

IS - 3

ER -